| Active ingredient (INN) |
|---|
| Avanafil |
| Brand names | SPEDRA avanafil |
|---|
| ATC level 5 | G04BE10 |
|---|
| ATC level 4 | G04BE |
|---|
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | A Menarini Australia Pty Ltd, Camber Pharmaceuticals, Inc. |
|---|
| Registrations on file | 6 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| SPEDRA avanafil | 100 mg | — | 🇦🇺 AU | A Menarini Australia Pty Ltd | Active |
| SPEDRA avanafil | 200 mg | — | 🇦🇺 AU | A Menarini Australia Pty Ltd | Active |
| SPEDRA avanafil | 50 mg | — | 🇦🇺 AU | A Menarini Australia Pty Ltd | Active |
| Avanafil | 50mg/1 | tablet | 🇺🇸 US | Camber Pharmaceuticals, Inc. | Active |
| Avanafil | 100mg/1 | tablet | 🇺🇸 US | Camber Pharmaceuticals, Inc. | Active |
| Avanafil | 200mg/1 | tablet | 🇺🇸 US | Camber Pharmaceuticals, Inc. | Active |